UK expert panel recommends COVID booster jabs for over-50s

By: |
September 14, 2021 5:57 PM

The Joint Committee on Vaccination and Immunisation's (JCVI) recommendation notes that six months after a second COVID vaccine dose is the optimum timing to boost immunity with another dose, with the Pfizer/BioNTech or Moderna vaccines among those ideal for use as a third jab.

The JCVI briefing comes ahead of a government statement laying out its winter strategy for tackling COVID-19 without having to resort to further lockdowns.The JCVI briefing comes ahead of a government statement laying out its winter strategy for tackling COVID-19 without having to resort to further lockdowns.

Britain’s expert advisory panel on Tuesday recommended that a third booster dose of a COVID-19 vaccine would be beneficial for people aged over 50 and frontline healthcare workers to boost their protection against the deadly virus over the winter months.

The Joint Committee on Vaccination and Immunisation’s (JCVI) recommendation notes that six months after a second COVID vaccine dose is the optimum timing to boost immunity with another dose, with the Pfizer/BioNTech or Moderna vaccines among those ideal for use as a third jab.

“Getting a dose too early may mean they do not need it as they still have a high level of protection, and as we’ve seen with the gap between the first and second dose, you don’t want to have it too early,” JCVI Chair Professor Wei Shen Lim told reporters at a briefing on Tuesday.

He also indicated a recurrent booster every six months may not be needed but it is too early to be sure about that.
England’s Deputy Chief Medical Officer Professor Jonathan Van-Tam said following the JCVI decision, he expects the boosters to be offered “within days” and they will be taking place at mass vaccination centres and GPs.

Van-Tam warned of a “bumpy” winter ahead despite the vaccines having been “incredibly successful” and had so far prevented an estimated 24 million COVID-19 cases and 112,000 deaths. “But we also know that this pandemic is still active. We are not past the pandemic, we are in an active phase still,” he said.

“We know that this winter could quite possibly be bumpy at times and we know that other respiratory viruses such as flu and RSV are highly likely to make their returns,” he added. The JCVI briefing comes ahead of a government statement laying out its winter strategy for tackling COVID-19 without having to resort to further lockdowns.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1India’s cumulative Covid-19 vaccine coverage crosses 81.73 crore
2Mumbai sees 419 COVID-19 cases; tests near 1 crore mark
3Covid-19: Maharashtra reports 2,583 new cases, lowest since February 9; 28 deaths